American College of Cardiology

MARCH 30, 2025

Patients with severe aortic stenosis who were treated with either TAVR or surgery had comparable rates of all-cause mortality or disabling stroke at five years, according to research presented during a Late-Breaking Clinical Trial session at ACC.25 25 in Chicago and simultaneously published in JACC.

TAVR 69

TAVR Stenosis Aortic Research 69

The New England Journal of Medicine

JANUARY 15, 2025

Among patients with asymptomatic severe aortic stenosis, early TAVR was superior to clinical surveillance in reducing the incidence of death, stroke, or unplanned hospitalization for cardiovascular causes.

Stenosis 74

Stenosis Aortic Aortic valve TAVR 74

DAIC

MAY 15, 2024

Getty Images milla1cf Wed, 05/15/2024 - 19:10 May 15, 2024 — A new study demonstrated parity between a minimally invasive procedure to replace the aortic valve in the heart— transcatheter aortic valve replacement (TAVR)—and surgical aortic valve replacement (SAVR). 1.11, p=0.70) with similar long-term mortality risks.

Aortic valve 105

Aortic valve TAVR Outcomes Aortic 105

DAIC

APRIL 30, 2024

SAVR after TAVR Surgical aortic valve replacement after prior TAVR is the fastest-growing cardiac surgery procedure in the U.S. The majority require explant of the TAVR device and SAVR, which significantly increases the risk of operative mortality and stroke. and 3.8%, respectively.

TAVR 111

TAVR Aortic valve Tricuspid Coronary Artery Bypass Graft 111

American College of Cardiology

FEBRUARY 18, 2025

The EARLY TAVR trial results demonstrate that early transcatheter aortic valve implantation in patients with asymptomatic severe aortic stenosis is superior to clinical surveillance in significantly reducing the composite primary outcome of death, stroke, or unplanned hospitalization for cardiovascular causes.

Stenosis 61

Stenosis Aortic Aortic valve TAVR 61

Becker's Hospital Review - Cardiology

JANUARY 5, 2024

A recent study found patients who undergo transcatheter aortic valve replacement have higher risk of stroke for up to two years after the procedure.

Aortic valve 69

Aortic valve TAVR Strokes Stroke 69

DAIC

MAY 1, 2024

According to the Centers for Disease Control and Prevention (CDC), heart disease and stroke rank as the first and fifth leading causes of death in the nation. About 276,000 patients have undergone a TAVR procedure in the United States.

Interventional Cardiology 105

Interventional Cardiology Aortic valve TAVR Peripheral Arterial Disease 105

American College of Cardiology

AUGUST 14, 2024

What is the relationship between diffusion-weighted magnetic resonance imaging (DW-MRI) total lesion number (TLN), individual lesion volume (ILV), and total lesion volume (TLV) with clinical stroke outcomes after transcatheter aortic valve replacement (TAVR)?

TAVR 53

TAVR Aortic valve Aortic Strokes 53

American College of Cardiology

APRIL 8, 2024

TAVR was found to bring no increased risks and was associated with substantially decreased rates of death or stroke at one year in low-risk patients, compared with surgical aortic valve replacement (SAVR), according to results from the DEDICATE-DZHK6 study presented during a Late-Breaking Clinical Trial session at ACC.24

TAVR 56

TAVR Aortic valve Aortic Strokes 56

American College of Cardiology

OCTOBER 29, 2024

The goal of the PROTECTED TAVR trial was to evaluate the efficacy of intraprocedural cerebral embolic protection (CEP) in reducing strokes among patients undergoing transfemoral TAVR for aortic stenosis.

Aortic valve 45

Aortic valve Aortic TAVR Strokes 45

Cardiology Update

NOVEMBER 26, 2023

In light of the growing number of patients undergoing transcatheter aortic valve replacement (TAVR), there is an increasing demand for data regarding the management of failed TAVR procedures, including the possibility of a repeat TAVR intervention. vs. 19.0%, p=0.57), as well as stroke at 30 days (2.0%

TAVR 52

TAVR Aortic valve Outcomes Aortic 52

DAIC

JULY 2, 2024

Multiple Randomized Trials Prove More Stroke Patients Can Benefit from Thrombectomy 4. Atlantic Health System’s Morristown Medical Center Tops 5,000 TAVR Procedures 8. Medtronic Launches Steerant Aortic Guidewire for EVAR and TEVAR Procedures 9. Supercharging the ECG: AI set to Revolutionize the Diagnostic Cardiology Market 7.

Blood Pressure 105

Blood Pressure TAVR Technology Aortic 105

American College of Cardiology

OCTOBER 29, 2024

In women with symptomatic, severe aortic stenosis (AS), TAVR with the balloon-expandable valve was superior to surgical aortic valve replacement in terms of the composite rate of death, stroke and rehospitalization at one-year follow-up, according to a pooled analysis of patient-level data from RHEIA and PARTNER 3 trials presented at TCT 2024.

TAVR 49

TAVR Aortic valve Aortic Stenosis 49

DAIC

JANUARY 29, 2024

Cardiac Surgery after Transcatheter Aortic Valve Replacement: Trends and Outcomes The researchers set out to document trends and outcomes in cardiac surgery following transcatheter aortic valve replacement (TAVR), a topic gaining importance as reports of subsequent cardiac operations and early TAVR explantations increase.

Research 111

Research TAVR Aortic valve Atrial Fibrillation 111

DAIC

APRIL 9, 2024

The SMART trial is the first randomized head-to-head comparison of the two most widely used TAVR devices—the supra-annular self-expanding Evolut PRO/PRO+/FX and the balloon-expandable SAPIEN 3/3 Ultra. The trial enrolled 716 patients who underwent TAVR at 83 international sites in North America, Europe and the Middle East.

TAVR 59

TAVR Aortic valve Aortic Anatomy 59

Circulation: Cardiovascular Interventions

MARCH 26, 2025

BACKGROUND:Current guidelines recommend surgical aortic valve replacement (SAVR) for patients with severe aortic stenosis and unfavorable iliofemoral access. The primary outcome was a composite of death from any cause, stroke/transient ischemic attack, and procedure-related or valve-related hospitalization at 30 days and at 1 year.

Aortic valve 40

Aortic valve Aortic Stenosis TAVR 40

DAIC

MARCH 12, 2024

A cost-effectiveness analysis demonstrates the positive economic value of transcatheter aortic valve replacement (TAVR) using Evolut TAVR compared to surgical aortic valve replacement (SAVR) for low-risk patients. The findings showed a strong economic benefit of Evolut TAVR for low-risk patients from a U.S.

TAVR 52

TAVR Aortic valve Aortic Stenosis 52

Open Heart

MAY 12, 2023

Objective To evaluate whether transcatheter or surgical aortic valve replacement (TAVR or SAVR) affects clinical and haemodynamic outcomes in symptomatic patients with moderately-severe aortic stenosis (AS). <aortic valve area (AVA)<1.5 <aortic valve area (AVA)<1.5 cm 2 , 3.0<peak cm 2 , 3.0<peak

Aortic valve 52

Aortic valve Aortic Stenosis TAVR 52

Circulation

NOVEMBER 11, 2024

Seven studies showed that TAVR patients had a similar 1-year stroke risk to SAVR patients (OR 0.92, 95% CI 0.64 In the TIA case, there was no evidence of a significant difference between TAVR and SAVR in the risk of having a transient ischemic attack within 30 days following surgery (OR 0.93, 95% CI 0.24 to 1.17, p=0.30, I2 3%).

Aortic valve 40

Aortic valve Aortic TAVR Strokes 40

American College of Cardiology

APRIL 24, 2024

He then examines the temporal trends and clinical implications of ischemic stroke in women with atrial fibrillation. Eagle looks at a scientific statement from the American Heart Association on the diagnosis and management of cardiac sarcoidosis.

Atrial Fibrillation 56

Atrial Fibrillation TAVR Strokes Stroke 56

Journal of the American Heart Association

FEBRUARY 13, 2024

BackgroundAcute ischemic stroke complicates 2% to 3% of transcatheter aortic valve replacements (TAVRs). The aortic arch morphology was determined via a manual review of the pre‐TAVR computed tomography images. The aortic arch morphology was determined via a manual review of the pre‐TAVR computed tomography images.

Aortic valve 40

Aortic valve Anatomy Aortic TAVR 40

Circulation

OCTOBER 25, 2023

Background:The optimal treatment in patients with severe aortic stenosis (AS) and small aortic annulus (SAA) remains to be determined. Participants were 151 patients with severe AS and SAA (mean diameter &lt;23 mm) were randomized (1:1) to TAVR (n=77) vs SAVR (n=74), The primary outcome was impaired valve hemodynamics (i.e.

Aortic valve 40

Aortic valve Aortic TAVR Stenosis 40

European Journal of Heart Failure

JANUARY 31, 2024

TAVR in heart failure. ABSTRACT Patients with severe aortic stenosis (AS) may develop heart failure (HF), the presence of which has traditionally been deemed as a final stage in AS progression with poor outcomes. The prognostic covariates and optimal timing of TAVR in patients with less than severe AS remain unclear.

Aortic valve 40

Aortic valve Heart Failure Aortic TAVR 40

The British Journal of Cardiology

FEBRUARY 20, 2024

Patients with bicuspid aortic valves (BAV) are predisposed to the development of aortic stenosis. We performed a pairwise meta-analysis, comparing the efficacy of transcatheter aortic valve replacement (TAVR) versus surgical aortic valve replacement (SAVR) in patients with BAV. to 4.58, p=0.04).

Aortic valve 40

Aortic valve Bicuspid/Mitral Aortic TAVR 40

Coronary Artery Disease Journal

MAY 13, 2024

Objective To investigate the impact of prior coronary artery bypass grafting (CABG) and coronary lesion complexity on transcatheter aortic valve replacement (TAVR) outcomes for aortic stenosis. The CABG SYNTAX score did not influence the prognosis after TAVR. The median CABG SYNTAX score was 16 (interquartile range: 9.0–23),

Coronary Artery Bypass Graft 40

Coronary Artery Bypass Graft Aortic valve Aortic Stenosis 40

Open Heart

JANUARY 19, 2023

Objective Postprocedural ischaemic and bleeding risks after transcatheter aortic valve replacement (TAVR) remain a major concern. We aimed to assess the accuracy of percutaneous coronary intervention (PCI)-derived models and the performance of a recalibrated model that included variables more applicable to TAVR.

Aortic valve 52

Aortic valve TAVR Aortic Myocardial Infarction 52

Circulation

OCTOBER 23, 2023

Background: Atrial fibrillation (AF) is common in patients undergoing transcatheter aortic valve replacement (TAVR) and is associated with increased risk of bleeding and stroke. Patients were randomized 1:1 to TAVR+LAAO or TAVR+medical therapy. For the composite primary endpoint, TAVR+.LAAO

Aortic valve 40

Aortic valve Atrial Fibrillation TAVR Aortic 40

Journal of the American Heart Association

FEBRUARY 14, 2025

BackgroundValveinvalve transcatheter aortic valve replacement (TAVR) is a recognized alternative for treating the structural valve deterioration of bioprosthetic valves. Recent guidelines and trials have expanded the indications for TAVR to include younger patients with structural valve deterioration.

Aortic valve 40

Aortic valve Aortic TAVR Outcomes 40

Journal of Cardiovascular Pharmacology

NOVEMBER 21, 2023

Abstract: Transcatheter aortic valve replacement (TAVR) is an interventional procedure performed in patients with severe aortic stenosis and often required perioperative antiplatelet therapy. Most previous studies have focused on antiplatelet therapy following TAVR.

Aortic valve 40

Aortic valve Aortic TAVR Myocardial Infarction 40

Circulation: Cardiovascular Interventions

OCTOBER 22, 2023

Background:Atherosclerotic cardiovascular disease (ASCVD) is highly prevalent in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement (TAVR). Exposure of interest was PVD. Primary outcome was all-cause mortality. 2VB-PVD, HR 1.12; 95% CI, 1.09-1.15, 1.15, and 3VB-PVD, HR 1.31; 95% CI, 1.26-1.36).

Aortic valve 40

Aortic valve Aortic TAVR Outcomes 40

Journal of the American Heart Association

MARCH 21, 2025

BackgroundCurrent guidelines and expert consensus recommend lifelong single antiplatelet therapy for patients undergoing transcatheter aortic valve replacement who have no indication for anticoagulation or dual antiplatelet therapy. Journal of the American Heart Association, Ahead of Print.

Aortic valve 40

Aortic valve Aortic Myocardial Infarction TAVR 40

Circulation

NOVEMBER 11, 2024

Introduction:Subclinical leaflet thrombosis is an increasingly recognized complication in patients undergoing transcatheter aortic valve replacement (TAVR). Patients with hypoattenuated leaflet thickening (HALT) and reduced leaflet motion (RELM) have a higher incidence of strokes and transient ischemic attacks.

Aortic valve 40

Aortic valve Thrombosis Aortic TAVR 40

DAIC

FEBRUARY 15, 2024

Transcatheter Mitral Valve Repair is Cost-Effective in Heart Failure Patients TAVR Expected to See Rapid Growth in Next 5 years FDA Clears Abbott Amplatzer Amulet LAA Occluder to Reduce Stroke in People With Atrial Fibrillation Portico TAVR System Found Safe and Effective for High-Risk Surgical Patients Portico TAVR System Reduces Severe (..)

Tricuspid 102

Tricuspid Heart Valves Quality of Life Bicuspid/Mitral 102

The New England Journal of Medicine

NOVEMBER 22, 2023

Among patients at low surgical risk who underwent TAVR or surgery, there was no apparent difference between groups in the incidence of the composite end point of death, stroke, or rehospitalization at 5 years.

Aortic valve 40

Aortic valve TAVR Aortic Strokes 40

DAIC

FEBRUARY 29, 2024

24 will focus on the following three current guideline updates: American College of Cardiology (ACC)/American Heart Association (AHA) Guidelines 2023 Atrial Fibrillation Guideline - Pharmacology II: Strokes vs. Bleeds, What Do the Guidelines Tell Us About Practical Management in A-fib? The Guidelines Sessions at ACC.24

Aortic valve 103

Aortic valve Myocardial Infarction Aortic Blood Pressure 103

Society of Thoracic Surgeons - Congenital

OCTOBER 17, 2023

Database, Study in Low-Risk Patients Reveals 5-year Survival Rate of 93% October 17, 2023, Chicago, IL – A study published today in The Annals of Thoracic Surgery demonstrates outstanding long-term survival following low-risk isolated surgical aortic valve replacement (SAVR). The average age of patients was 74.2

Aortic valve 40

Aortic valve TAVR Aortic Cardiothoracic 40

Cardiology Update

APRIL 9, 2024

SMART 4 ( NCT04722250 ) studied patients with severe aortic stenosis and a small aortic annulus who underwent transcatheter aortic valve replacement (TAVR). A total of 716 patients underwent TAVR with either a self-expanding supraannular valve or a balloon-expandable valve. vs. 6.2%) and stroke (2.9%

Angina 52

Angina Myocardial Infarction Aortic valve Coronary Artery Disease 52